Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Dexcom (DXCM)

Dexcom (DXCM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,846,692
  • Shares Outstanding, K 98,126
  • Annual Sales, $ 2,449 M
  • Annual Income, $ 154,700 K
  • 60-Month Beta 1.05
  • Price/Sales 12.48
  • Price/Cash Flow 81.89
  • Price/Book 13.96
Trade DXCM with:

Options Overview Details

View History
  • Implied Volatility 58.99% ( -4.76%)
  • Historical Volatility 51.08%
  • IV Percentile 96%
  • IV Rank 83.93%
  • IV High 64.79% on 05/09/22
  • IV Low 28.71% on 08/13/21
  • Put/Call Vol Ratio 0.61
  • Today's Volume 843
  • Volume Avg (30-Day) 683
  • Put/Call OI Ratio 0.94
  • Today's Open Interest 32,447
  • Open Int (30-Day) 27,161

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.71
  • Number of Estimates 10
  • High Estimate 0.87
  • Low Estimate 0.52
  • Prior Year 0.76
  • Growth Rate Est. (year over year) -6.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
302.61 +10.62%
on 05/12/22
503.78 -33.55%
on 04/21/22
-164.06 (-32.89%)
since 04/13/22
3-Month
302.61 +10.62%
on 05/12/22
539.06 -37.90%
on 04/04/22
-85.82 (-20.41%)
since 02/11/22
52-Week
302.61 +10.62%
on 05/12/22
659.45 -49.24%
on 11/18/21
+10.78 (+3.33%)
since 05/13/21

Most Recent Stories

More News
Stocks Surge as Fed Chair Powell Eases Fears of Aggressive Tightening

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +2.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up...

$SPX : 4,023.89 (+2.39%)
SPY : 401.72 (+2.39%)
$DOWI : 32,196.66 (+1.47%)
DIA : 322.23 (+1.45%)
$IUXX : 12,387.40 (+3.70%)
QQQ : 301.94 (+3.71%)
TEAM : 188.90 (+12.28%)
ZM : 94.84 (+11.62%)
ZS : 153.23 (+11.33%)
CRWD : 156.29 (+11.79%)
OKTA : 97.70 (+11.42%)
NVDA : 177.06 (+9.47%)
Stocks Partially Recover as Powell Eases Rate-Hike Fears

What you need to know… The S&P 500 Index ($SPX ) (SPY ) this morning is up by +1.88%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.79%....

$SPX : 4,023.89 (+2.39%)
SPY : 401.72 (+2.39%)
$DOWI : 32,196.66 (+1.47%)
DIA : 322.23 (+1.45%)
$IUXX : 12,387.40 (+3.70%)
QQQ : 301.94 (+3.71%)
ZM : 94.84 (+11.62%)
ZS : 153.23 (+11.33%)
CRWD : 156.29 (+11.79%)
TEAM : 188.90 (+12.28%)
OKTA : 97.70 (+11.42%)
NVDA : 177.06 (+9.47%)
Stocks Close Just Mildly Lower after Fed Comments Spark Short-Covering

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 4,023.89 (+2.39%)
SPY : 401.72 (+2.39%)
$DOWI : 32,196.66 (+1.47%)
DIA : 322.23 (+1.45%)
$IUXX : 12,387.40 (+3.70%)
QQQ : 301.94 (+3.71%)
AAPL : 147.11 (+3.19%)
NVDA : 177.06 (+9.47%)
MSFT : 261.12 (+2.26%)
DXCM : 334.74 (+7.45%)
AMD : 95.12 (+9.26%)
SYF : 33.55 (+1.57%)
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond

Despite struggles in the stock market, it's not all doom and gloom for these companies.

DXCM : 334.74 (+7.45%)
MSFT : 261.12 (+2.26%)
Dexcom Announces Upcoming Conference Presentations

DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor conferences:...

DXCM : 334.74 (+7.45%)
Stocks End Volatile Week on Negative Note as T-Note Yields Climb

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -0.57%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 4,023.89 (+2.39%)
SPY : 401.72 (+2.39%)
$DOWI : 32,196.66 (+1.47%)
DIA : 322.23 (+1.45%)
$IUXX : 12,387.40 (+3.70%)
QQQ : 301.94 (+3.71%)
UAA : 11.04 (+3.76%)
ILMN : 233.56 (+7.42%)
NKE : 113.01 (+4.74%)
ZS : 153.23 (+11.33%)
CRWD : 156.29 (+11.79%)
OKTA : 97.70 (+11.42%)
3 Surefire Investments You'll Thank Yourself for Later

Don't let a little bit of weakness right now distract you from bigger-picture prizes.

MCD : 245.04 (+0.35%)
PINS : 21.47 (+6.50%)
DXCM : 334.74 (+7.45%)
DexCom (DXCM) Q1 Earnings Miss, Revenues Beat Estimates

Despite a decline in bottom line, DexCom's (DXCM) first-quarter results benefit from domestic and international revenue growth and solid new customer additions.

UNH : 485.40 (+1.38%)
ALKS : 26.88 (+1.17%)
DXCM : 334.74 (+7.45%)
QGEN : 46.13 (+4.20%)
Is DexCom Stock a Buy Now?

The diabetes market is full of growth potential.

DXCM : 334.74 (+7.45%)
DexCom (DXCM) Q1 2022 Earnings Call Transcript

DXCM earnings call for the period ending March 31, 2022.

DXCM : 334.74 (+7.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of...

See More

Key Turning Points

3rd Resistance Point 363.99
2nd Resistance Point 350.83
1st Resistance Point 342.79
Last Price 334.74
1st Support Level 321.59
2nd Support Level 308.43
3rd Support Level 300.39

See More

52-Week High 659.45
Fibonacci 61.8% 523.14
Fibonacci 50% 481.03
Fibonacci 38.2% 438.92
Last Price 334.74
52-Week Low 302.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar